EP 1701719 A1 20060920 - CHP-GEMCITABIN COMBINED AGENT AND USE THEREOF AS ANTI-TUMOURAL ACTIVE SUBSTANCES
Title (en)
CHP-GEMCITABIN COMBINED AGENT AND USE THEREOF AS ANTI-TUMOURAL ACTIVE SUBSTANCES
Title (de)
CHP-GEMCITABIN-KOMBINATIONSMITTEL UND IHRE VERWENDUNG ALS ANTITUMORWIRKSTOFFE
Title (fr)
AGENTS DE COMBINAISON CHP-GEMCITABINE ET UTILISATION EN TANT QU' AGENTS ANTITUMORAUX
Publication
Application
Priority
- DE 2004002760 W 20041213
- DE 10359828 A 20031212
Abstract (en)
[origin: WO2005056005A1] The invention relates to combined agents, comprising cis-hydroxy-proline (CHP) and gemcitabin, in addition to the use of said agents in the prophylaxis of tumours and therapy.
IPC 8 full level
A61K 31/401 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/401 (2013.01 - EP US); A61K 31/506 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2005056005A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005056005 A1 20050623; AU 2004296129 A1 20050623; AU 2004296129 A2 20050623; BR PI0417513 A 20070306; CA 2548605 A1 20050623; CN 1889946 A 20070103; DE 10359828 A1 20050728; EP 1701719 A1 20060920; JP 2007513894 A 20070531; MX PA06006717 A 20070504; RU 2006125081 A 20080120; US 2007207980 A1 20070906; ZA 200605707 B 20080227
DOCDB simple family (application)
DE 2004002760 W 20041213; AU 2004296129 A 20041213; BR PI0417513 A 20041213; CA 2548605 A 20041213; CN 200480036706 A 20041213; DE 10359828 A 20031212; EP 04816269 A 20041213; JP 2006543364 A 20041213; MX PA06006717 A 20041213; RU 2006125081 A 20041213; US 59640904 A 20041212; ZA 200605707 A 20041213